Profile data is unavailable for this security.
About the company
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.
- Revenue in CAD (TTM)53.38m
- Net income in CAD-32.12m
- Incorporated2003
- Employees70.00
- LocationValeo Pharma Inc16667 Hymus BlvdKIRKLAND H9H 4R9CanadaCAN
- Phone+1 (514) 693-8832
- Fax+1 (514) 693-8832
- Websitehttps://valeopharma.com/
More ▼